PEG
57
2
DNB
36
4
DHI
54
6
TROW
58
2
AIZ
73
5
CB
46
-2
FRT
58
-5
DVN
39
3
AEP
56
3
SEE
57
2
EFX
66
5
SRCL
40
6
STX
50
5
MNST
65
5
SNA
60
5
NSC
42
2
TXN
39
3
EXPE
43
-21
WM
70
2
AAP
33
4
PEG
57
2
DNB
36
4
DHI
54
6
TROW
58
2
AIZ
73
5
CB
46
-2
FRT
58
-5
DVN
39
3
AEP
56
3
SEE
57
2
EFX
66
5
SRCL
40
6
STX
50
5
MNST
65
5
SNA
60
5
NSC
42
2
TXN
39
3
EXPE
43
-21
WM
70
2
AAP
33
4
Financhill
Back

Denali Therapeutics Stock Predictions

20 Most Hated Stocks on Wall Street

Click here to see the full list and protect yourself before it's too late.
Sell
41

DNLI
Denali Therapeutics

Last Price:
17.14
Seasonality Move:
-0.16%

7 Day Trial

ALL ACCESS PASS

$ 7

This DeFi Coin Could 10x Soon... I Advise You Get In Now!

Discover this DeFi diamond before the next surge

Denali Therapeutics Stock Forecast

  • Over the next 52 weeks, Denali Therapeutics has on average historically risen by 15.7% based on the past 6 years of stock performance.
  • Denali Therapeutics has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Denali Therapeutics Stock Undervalued?
    The current Denali Therapeutics [DNLI] share price is $17.14. The Score for DNLI is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • DNLI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Denali Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Denali Therapeutics has on average historically risen by 15.7% based on the past 6 years of stock performance.

Denali Therapeutics Stock Rating

Sell
41
Denali Therapeutics (DNLI) is a Sell

Is Denali Therapeutics overpriced?

  • Denali Therapeutics has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Denali Therapeutics Stock Price History

Is DNLI stock going to rise?

  • The current trend is relatively stagnant and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
denalitherapeutics.com

52-Week Data

52-Week High:
33.31
52-Week Low:
14.56

Prediction Charts

Market Cap:
2.44B
Price in USD:
17.14
Volume:
859.79K
Beta:
1.50

Technical Analysis

SMA50:
18.87
SMA100:
18.84
SMA200:
20.37
52-Wk Change:
-33.72%

Stock Predictions

  • Is Denali Therapeutics stock public?
    Yes, Denali Therapeutics is a publicly traded company.
  • What is the Denali Therapeutics stock quote today?
    The Denali Therapeutics stock price is 17.14 USD today.
  • How to buy Denali Therapeutics stock online?
    You can buy Denali Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-16 17.59 17.34 17.60 17.15
Apr-17 17.38 16.83 17.56 16.79
Apr-18 16.72 16.60 16.95 16.54
Apr-19 16.50 16.00 16.80 15.92
Apr-22 16.00 15.99 16.28 15.48
Apr-23 16.14 16.09 16.80 16.02
Apr-24 16.10 15.56 16.30 15.47
Apr-25 15.25 14.96 15.25 14.56
Apr-26 15.08 15.43 15.49 14.90
Apr-29 15.64 15.60 15.96 15.39
Apr-30 15.34 15.44 15.58 15.21
May-1 15.53 16.15 16.72 15.40
May-2 16.41 16.79 16.94 15.92
May-3 17.17 17.14 17.90 17.04

Denali Therapeutics Earnings

Denali Therapeutics Earnings Report: Per Share Denali Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Denali Therapeutics Forecast Revenue Growth

Denali Therapeutics Stock Analysis: Historical quarterly revenues per share for Denali Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.49 per share, and an increase next year of $0.10 per share.

* Denali Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.